Scarica l'app Stockscreener
297.80
0.09%
0.325
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WST Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$297.47
Aprire:
$299.99
Volume 24 ore:
14,199
Relative Volume:
0.02
Capitalizzazione di mercato:
$21.40B
Reddito:
$2.96B
Utile/perdita netta:
$487.70M
Rapporto P/E:
44.61
EPS:
6.6758
Flusso di cassa netto:
$344.00M
1 W Prestazione:
+8.31%
1M Prestazione:
+13.85%
6M Prestazione:
+38.78%
1 anno Prestazione:
-3.30%
Intervallo 1D:
$297.55
$301.00
Intervallo di 1 settimana:
$274.43
$322.34
Portata 52W:
$187.43
$348.90
West Pharmaceutical Services Inc Stock (WST) Company Profile
Nome
West Pharmaceutical Services Inc
Settore
Industria
Telefono
(610) 594-2900
Indirizzo
530 HERMAN O. WEST DRIVE, EXTON, PA
Confronta WST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
297.60 | 21.40B | 2.96B | 487.70M | 344.00M | 6.6758 |
|
ISRG
Intuitive Surgical Inc
|
542.32 | 193.74B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
186.41 | 53.26B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
258.05 | 37.87B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
75.76 | 37.61B | 10.03B | 1.07B | 1.39B | 2.1549 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-15 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-06-24 | Iniziato | Barclays | Equal Weight |
| 2025-03-18 | Iniziato | Evercore ISI | Outperform |
| 2025-02-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Iniziato | Citigroup | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-12 | Aggiornamento | UBS | Neutral → Buy |
| 2024-02-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-06-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-04-11 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-11-30 | Iniziato | UBS | Neutral |
| 2022-10-28 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Iniziato | Stephens | Equal-Weight |
| 2020-07-21 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-04-24 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Downgrade | Jefferies | Buy → Hold |
| 2019-04-23 | Iniziato | William Blair | Outperform |
| 2018-04-25 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Iniziato | Goldman | Neutral |
| 2017-10-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Iniziato | Stephens | Equal-Weight |
| 2017-09-15 | Aggiornamento | Jefferies | Hold → Buy |
| 2016-10-28 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Iniziato | Wells Fargo | Outperform |
| 2010-05-14 | Reiterato | UBS | Neutral |
| 2010-02-23 | Iniziato | Jefferies & Co | Buy |
| 2008-12-19 | Iniziato | UBS | Neutral |
Mostra tutto
West Pharmaceutical Services Inc Borsa (WST) Ultime notizie
Is West Pharmaceutical Services Inc. stock testing key support2025 Major Catalysts & Long Hold Capital Preservation Plans - newser.com
West Pharmaceutical stock rating reiterated at Outperform by Evercore ISI - Investing.com
Jefferies Adjusts Price Target on West Pharmaceutical Services to $365 From $335, Maintains Buy Rating - MarketScreener
West Pharmaceutical Services, Inc. Announces the Launch of its West Synchrony Prefillable Syringe System at CPHI Worldwide in Frankfurt, Germany - MarketScreener
How strong is West Pharmaceutical Services Inc. stock revenue growthPortfolio Risk Summary & Pattern Based Trade Signal System - newser.com
West Pharma (NYSE: WST) debuts Synchrony PFS for biologics, available Jan 2026 - Stock Titan
Why West Pharmaceutical Services Inc. stock could rally in 2025Quarterly Trade Report & Technical Entry and Exit Tips - newser.com
How sustainable is West Pharmaceutical Services Inc. stock dividend payout2025 Major Catalysts & Fast Entry and Exit Trade Plans - newser.com
Will West Pharmaceutical Services Inc. see short term momentumJuly 2025 Sector Moves & Daily Volume Surge Signals - newser.com
Can West Pharmaceutical Services Inc. stock surprise with quarterly results2025 Volatility Report & Smart Allocation Stock Tips - newser.com
Is West Pharmaceutical Services Inc. stock bottoming outMarket Activity Summary & Safe Entry Point Alerts - newser.com
What to do if you’re stuck in West Pharmaceutical Services Inc.Market Sentiment Review & Weekly Return Optimization Plans - newser.com
West Pharmaceutical Services (WST) Is Up 9.9% After Raising 2025 Guidance and Beating Q3 Expectations - Yahoo Finance
West Pharmaceutical Services (WST): Evaluating Valuation After Recent Share Price Momentum - Yahoo Finance
West Pharmaceutical Services, Inc. Experiences Revision in Its Stock Evaluation Metrics - Markets Mojo
West Pharmaceutical Services (WST) Margin Compression Reinforces Valuation Concerns Despite High-Quality Earnings - Sahm
R Squared Ltd Buys New Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services Inc Azioni (WST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.20%
1.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):